Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
Article
Statins and Insulin Resistance
Read time: 1h 1m 1s
About
Media
Watch time: 4m 57s
Articles
European Physicians Perspectives on Cholesterol Management and Inhibition of Cholesterol Absorption and Production
Citation:
European Cardiovascular Disease 2007;3(1):16–20
- Views:
237
- Downloads:
0
New Insights on Simvastatin and Ezetimibe in a Single Tablet
Citation:
European Cardiovascular Disease 2007;3(1):12–5
- Views:
326
- Downloads:
0
Magnetic Resonance Angiography Using the Intravascular Contrast Agent Vasovist
Citation:
European Cardiovascular Disease 2006;2(1):1–4
- Views:
120
- Downloads:
0
Interventional Cardiology for Coronary Artery Disease
Citation:
European Cardiovascular Disease 2006;2(1):1–3
- Views:
133
- Downloads:
0